KAZIA THERAPEUTICS MOVING!
(NASDAQ: KZIA) announced positive news this morning from its phase 1 clinical trial. Shares are $2.14 and there are 3400...
(NASDAQ: KZIA) announced positive news this morning from its phase 1 clinical trial. Shares are $2.14 and there are 3400...